Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

The Effect of Tai Chi and Therapy by Dance and Movement on Blood Irisin Levels in Older Adults Over 65 Years of Age.

3. maj 2022 opdateret af: Hana Polanska, Charles University, Czech Republic

The aim of this project is to estimate the effects of therapy with dance and movement and Tai Chi on irisin plasma levels, a myokine with proven neuroprotective effects, in the context of baseline levels of cognitive function and physical performance in seniors over 65 years of age.

It is empirically verified that physical activity can have a positive effect on cognitive function even in individuals with mild cognitive impairment. There may be a number of reasons why this is the case. Recently, research investigating the relationship between the secretion of certain myokines and their neuroprotective effects has gained importance. One of these myokines is irisin, which has recently been shown to have beneficial effects on the CNS by upregulating the expression of Brain Derived Neurotrophic Factor (BDNF) in the hippocampus in an animal model. Increased irisin levels as a consequence of exercise have recently been partially demonstrated in humans. What type of physical activity is most effective in terms of its effect on cognitive function in humans is another important scientific challenge. The possibility of influencing endocrine secretion of bioactive substances with proven effects on synaptic plasticity, neurogenesis and neuroprotection through effective therapies may help to combat neurodegenerative diseases, the prevalence of which is increasing with the average age of the population. According to Alzheimer's Disease International, 50 million people worldwide were affected by some form of neurodegenerative disease in 2017. The number of people affected is still rising. It is predicted that this number will reach 75 million sufferers by 2030 (https://www.alz.co.uk/research/statistics). Alzheimer's disease and multiple sclerosis are the two most common manifestations of neurodegenerative diseases. The effect of therapy with dance and movement and the effect of Tai Chi on blood irisin levels in the context of cognitive function and physical performance levels, has not yet been conclusively demonstrated.

Studieoversigt

Detaljeret beskrivelse

It is empirically verified that physical activity can have a positive effect on cognitive function even in individuals with mild cognitive impairment. There may be a number of reasons why this is the case. Recently, research investigating the relationship between the secretion of certain myokines and their neuroprotective effects has gained importance. One of these myokines is irisin, which has recently been shown to have beneficial effects on the CNS by upregulating the expression of Brain Derived Neurotrophic Factor (BDNF) in the hippocampus in an animal model. Increased irisin levels as a consequence of exercise have recently been partially demonstrated in humans. What type of physical activity is most effective in terms of its effect on cognitive function in humans is another important scientific challenge. The possibility of influencing endocrine secretion of bioactive substances with proven effects on synaptic plasticity, neurogenesis and neuroprotection through effective therapies may help to combat neurodegenerative diseases, the prevalence of which is increasing with the average age of the population. According to Alzheimer's Disease International, 50 million people worldwide were affected by some form of neurodegenerative disease in 2017. The number of people affected is still rising. It is predicted that this number will reach 75 million sufferers by 2030 (https://www.alz.co.uk/research/statistics). Alzheimer's disease and multiple sclerosis are the two most common manifestations of neurodegenerative diseases. The effect of therapy with dance and movement and the effect of Tai Chi on blood irisin levels in the context of cognitive function and physical performance levels, has not yet been conclusively demonstrated. The aim of this project is to estimate the effects of therapy with dance and movement and Tai Chi on irisin plasma levels, a myokine with proven neuroprotective effects, in the context of baseline levels of cognitive function and physical performance in seniors over 65 years of age.

Implementation of the project: the following personal data will be collected at the Consultation Room for Memory Disorders, AD Centrum Fakultní at the Královské Vinohrady Hospital (PPP AD FNKV): age, weight, height, sex, education, a brief medical history will be taken, current illness and current treatment will be determined, and a basic pharmacological and toxicological history will be taken. The probands who will be admitted to the experimental part of the project, based on the initial screening at the PPP AD FNKV, will have their cognitive function tested and 9 ml of venous blood drawn before and after the intervention at the PPP AD FNKV, and strength and physical performance tested at the UK FTVS. Thereafter, probands will be randomized to either the intervention groups or the control group. This randomized controlled trial will compare the effects of a movement and dance therapy based on Bartenieff fundamentals and the other type of intervention will be implemented as Tai Chi exercises. Both types of exercises are designed to place a greater emphasis on body perception, so that there is a connection between musculoskeletal coordination and movement in conjunction with an emotional experience focused on the ability to perceive bodily signals. This approach will activate cognitive functions more. The experimental part will be carried out with a time intensity of twice a week (90 min) for 12 weeks - all in two phases 09-2021 to 12-2021 and 09-2022 to 12-2022. The control group will be implemented on the principle of wait-list control group.

Characteristics of research participants: Based on the power analysis, we expect to recruit approximately 90 participants (age ≥ 65 - ≤ 80 years) from outpatients of the PPP AD FNKV and U3V UK FTVS participants, or other interested persons from Prague 6.

Individuals with advanced cognitive impairment, regular use of medications affecting cognitive performance, antidepressants, anxiolytics, and individuals with uncorrected hypertension and ischemic heart disease, acutee (especially infectious) disease, musculoskeletal disorders and chronic diseases limiting physical activity, as well as individuals in recovery after illness or injury cannot take part in the study.

Ethical aspects of research: The research will be conducted on seniors who will be enrolled in the research on the basis of voluntary informed consent. Since movement therapy has no negative side effects, it is an ethically conflict-free research from this perspective. On the other hand, a great benefit to society can be expected, in particular the development of a suitable exercise regimen that will be applicable to other age groups. Since the elderly are a specific and relatively easy to influence group, they will be adequately informed about the purpose of the research, and the benefits of the research for them and for the elderly population as a whole will be explained. Before signing the informed consent, the clarity and understanding of the information provided will be carefully checked.

Undersøgelsestype

Interventionel

Tilmelding (Forventet)

90

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Studiesteder

      • Prague, Tjekkiet
        • Rekruttering
        • Faculty Hospital Vinohrady
        • Kontakt:
      • Prague, Tjekkiet
        • Rekruttering
        • Faculty of Physical Education and Sport
        • Kontakt:

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

65 år til 80 år (Ældre voksen)

Tager imod sunde frivillige

Ja

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • Is 65 years - 80 years in age
  • His/her native language is Czech
  • Is willing to visit the testing centre two times within 3-4 months
  • Is willing to provide blood samples twice
  • Is willing to take part in the movement therapy intervention
  • is self-sufficient (handling finances, travelling without a chaperone, administration of medication, correct phone usage, filling forms, meal preparation)
  • Has good vision; Can read and write, glasses are acceptable
  • Has good hearing to hear and understand all instructions during examination
  • Can walk well (walking aids are acceptable) to attend all the examinations and move well enough to take part in the movement therapy

Exclusion Criteria:

  • Had been treated/Is currently being treated for the following psychiatric disorders: alcohol/medication/drug of abuse dependance, schizophrenia, psychotic disorder, bipolar disorder
  • Had larger physical imparment which would interfere with the ability to take part in the Dance Movement and Tai Chi interventions
  • Had severe neurological difficulties (epilepsy, stroke, severe head trauma, meningitis in the past 10 years, brain surgery, brain tumour, prolonged period(s) in an unconscious state - excluding general anaesthesia)
  • Underwent a surgery/procedure under general anaesthesia in the past three years or has a planned procedure/surgery under general anaesthesia in the next 6 months over the course of this trial
  • Is taking medication for depression or low mood

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Forebyggelse
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Enkelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Therapy by Dance and Movement
Participants assigned to this part take part in Dance Movement Therapy twice a week (90 minutes each) for the duration of three months.
Therapy by dance and movement is based on the principals of movement-analysis by Rudolf Laban and Irmgard Bartenieff. Participants will attend sessions twice a week (90 minutes each) for the duration of three months.
Ingen indgriben: Control to Dance Movement Therapy
Participants assigned to this arm take part in no particular activity for the three months.
Eksperimentel: Movement Therapy by Tai Chi
Participants assigned to this part take part inTai Chi class twice a week (90 minutes each) for the duration of three months.
Tai Chi is based on somatic approach. Participants will attend sessions twice a week (90 minutes each) for the duration of three months.
Ingen indgriben: Control to Tai Chi
Participants assigned to this arm take part in no particular activity for the three months.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Change in Irisin blood levels after 3 months of the intervention
Tidsramme: baseline to 3 months
Irisin levels measured from 9ml blood samples
baseline to 3 months
Difference in Irisin blood levels between the arms at 3 months
Tidsramme: 3 months
Irisin levels measured from 9ml blood samples
3 months

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Change in brain derived neurotrophic factor (BDNF) levels at 3 months
Tidsramme: baseline to 3 months
BDNF measured from a 9ml blood samples.
baseline to 3 months
Difference in brain derived neurotrophic factor (BDNF) levels at 3 months between the arms
Tidsramme: 3 months
BDNF measured from a 9ml blood samples.
3 months
Change from baseline cognitive function in the Amnesia Light and Brief Assessment (ALBA) at 3 months better outcome
Tidsramme: baseline to 3 months
ALBA is a validated measure assessing memory. The scale spans 0-12 points with higher number of points signifying better outcome
baseline to 3 months
Difference in cognitive function in the Amnesia Light and Brief Assessment (ALBA) between the arms at 3 months
Tidsramme: 3 months
ALBA is a validated measure assessing memory. The scale spans 0-12 points with higher number of points signifying better outcome
3 months
Ændring fra kognitiv basisfunktion i semantisk ordhukommelse (kategori: dyr, 1 min) efter 3 måneder
Tidsramme: baseline til 3 måneder
Semantisk ordhukommelse er et mål for kognitiv funktion, resultater spænder fra 0-cca 40, flere point betyder bedre resultat
baseline til 3 måneder
Difference in cognitive function in Semantic word recollection (category: animals, 1 min) between the arms at 3 months
Tidsramme: 3 months
Semantic word recollection is a measure of cognitive function, results range from 0-cca 40, more points signify better outcome
3 months
Change in cognitive function in Semantic word recollection (category: letters, 1 min) at 3 months
Tidsramme: baseline to 3 months
Semantic word recollection is a measure of cognitive function, results range from 0-cca 40, more points signify better outcome
baseline to 3 months
Difference in cognitive function in Semantic word recollection (category: letters, 1 min) at 3 months between the arms
Tidsramme: 3 months
Semantic word recollection is a measure of cognitive function, results range from 0-cca 40, more points signify better outcome
3 months
Ændring fra baseline kognitiv funktion i Rey Auditory Verbal Learning Test (RAVLT) efter 3 måneder
Tidsramme: baseline til 3 måneder
RAVLT er et valideret mål for kognitiv funktion, det har 8 underskalaer, hver af dem spænder fra 0-15, målt i råscore, der er forbundet med aldersafhængig befolkningsnorm
baseline til 3 måneder
Difference in cognitive function in Rey Auditory Verbal Learning Test (RAVLT) at 3 months between the arms
Tidsramme: 3 months
RAVLT is a validated measure of cognitive function, it has 8 subscales, each of them ranging from 0-15, measured in raw scores which are connected to age-dependent population norm
3 months
Ændring i kognitiv basisfunktion i Wechsler Adult Intelligence Scale, tredje udgave (WAIS III) - "Symboler" undertest efter 3 måneder
Tidsramme: baseline til 3 måneder
WAIS III, deltest "Symboler" er et valideret mål for kognitiv funktion, punktskalaen går fra 0-133 med større pointopnåelse signalerer bedre resultat
baseline til 3 måneder
Difference in cognitive function in Wechsler Adult Intelligence Scale, Third edition (WAIS III) - "Symbols" subtest at 3 months between the arms
Tidsramme: 3 months
The WAIS III, subtest "Symbols" is a validated measure of cognitive function, the point scale ranges from 0-133 with larger point attainment signalling better outcome
3 months
Ændring i kognitiv basisfunktion i Trail Making Test (TMT), del A & B efter 3 måneder
Tidsramme: baseline til 3 måneder
TMT er et valideret mål for kognitiv funktion, tiden efter afslutning måles
baseline til 3 måneder
Difference in cognitive function in Trail Making Test (TMT), Parts A & B at 3 months between the arms
Tidsramme: 3 months
The TMT is a validated measure of cognitive function, the time upon completion is measured
3 months
Change in the Clock Drawing Test at 3 months
Tidsramme: baseline to 3 months
A validated measure where participant is asked to draw a clock face with the time 23:20
baseline to 3 months
Difference in the Clock Drawing Test at 3 months between the arms
Tidsramme: 3 months
A validated measure where participant is asked to draw a clock face with the time 23:20
3 months
Change in Line Picture Production test at 3 months
Tidsramme: baseline to 3 months
Participant is asked to produce as many as possible pictures consisting from 4 straight lines in 1 minute.
baseline to 3 months
Difference in Line Picture Production test at 3 months between the arms
Tidsramme: 3 months
Participant is asked to produce as many as possible pictures consisting from 4 straight lines in 1 minute.
3 months
Change in Picture Naming and Immediate Recall test (PICNIR) at 3 months
Tidsramme: Baseline to 3 months
Cognitive measure where participants first write down names of 20 pictures and then are asked to recall these names within 1 minute
Baseline to 3 months
Difference in Picture Naming and Immediate Recall test (PICNIR) at 3 months between the arms
Tidsramme: 3 months
Cognitive measure where participants first write down names of 20 pictures and then are asked to recall these names within 1 minute.
3 months
Change in baseline mood in Geriatric Depression Scale at 3 months.
Tidsramme: baseline to 3 months
A self-report measure of mood, measured on 0-15 point scale, higher point attainment signifies worse outcome.
baseline to 3 months
Difference in mood in Geriatric Depression Scale at 3 months.
Tidsramme: 3 months
A self-report measure of mood, measured on 0-15 point scale, higher point attainment signifies worse outcome.
3 months
Ændring fra baseline selvforsyning selvrapporteret i spørgeskema over funktionel tilstand (forkortelse på originalsproget: subjektiv FAQ-CZ) efter 3 måneder
Tidsramme: baseline til 3 måneder
FAQ-CZ er et selvrapporterende mål for selvforsyning, det måles på en skala fra 0-30 med højere pointopnåelse signalerer dårligere resultat
baseline til 3 måneder
Difference in self-sufficiency self-reported in Questionnaire of functional state (abbreviation in original language: subjective FAQ-CZ) at 3 months between the arms
Tidsramme: 3 months
FAQ-CZ is a self-report measure of self-sufficiency, it is measured on a scale of 0-30 with higher point attainment signalling worse outcome
3 months
Change in Sarcopenia at 3 months
Tidsramme: baseline to 3 months
An ultrasound imaging method for diagnosing sarcopenia based on changes in muscle geometric proportions: muscle thickness (MT), pennation angle (PA), fiber length (FL), and ultrasound sarcopenic index (USI) calculated as FL/MT.
baseline to 3 months
Difference in Sarcopenia at 3 months between the arms
Tidsramme: 3 months
An ultrasound imaging method for diagnosing sarcopenia based on changes in muscle geometric proportions: muscle thickness (MT), pennation angle (PA), fiber length (FL), and ultrasound sarcopenic index (USI) calculated as FL/MT.
3 months
Change in knee extensor isometric strength and static fatigue at 3 months
Tidsramme: baseline to 3 months
Knee extensor isometric strength and static fatigue were measured by a stationary dynamometer: isometric torque (Nm), and fatigue index calculated as the Area Under Force vs. Time Curve of right knee extensor during a sustained 30 s maximal voluntary muscle contraction. Handgrip strength.
baseline to 3 months
Difference in knee extensor isometric strength and static fatigue at 3 months between the arms
Tidsramme: 3 months
Knee extensor isometric strength and static fatigue were measured by a stationary dynamometer: isometric torque (Nm), and fatigue index calculated as the Area Under Force vs. Time Curve of right knee extensor during a sustained 30 s maximal voluntary muscle contraction. Handgrip strength.
3 months
Change in short physical performance battery (SPPB) at 3 months
Tidsramme: baseline to 3 months
The short physical performance battery (SPPB) is a group of measures that combines the results of the gait speed, chair stand and balance tests. It is used as a predictive tool for possible disability and can aid in the monitoring of function in older people.
baseline to 3 months
Difference in short physical performance battery (SPPB) at 3 months between the arms
Tidsramme: 3 months
The short physical performance battery (SPPB) is a group of measures that combines the results of the gait speed, chair stand and balance tests. It is used as a predictive tool for possible disability and can aid in the monitoring of function in older people.
3 months
Change in Body Composition at 3 months
Tidsramme: baseline to 3 months
Body composition by a bioelectrical impedance analysis (BIA).
baseline to 3 months
Difference in Body Composition at 3 months between the arms
Tidsramme: 3 months
Body composition by a bioelectrical impedance analysis (BIA).
3 months

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

1. august 2021

Primær færdiggørelse (Forventet)

30. januar 2023

Studieafslutning (Forventet)

30. januar 2023

Datoer for studieregistrering

Først indsendt

3. maj 2022

Først indsendt, der opfyldte QC-kriterier

3. maj 2022

Først opslået (Faktiske)

5. maj 2022

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

5. maj 2022

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

3. maj 2022

Sidst verificeret

1. maj 2022

Mere information

Begreber relateret til denne undersøgelse

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

UBESLUTET

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner